flutamide and osteoprotegerin

flutamide has been researched along with osteoprotegerin in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	2 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Härkönen, PL; Hentunen, TA; Michael, H; Väänänen, HK	1
Blair, JM; Jackson, P; Rowe, A; Russell, PJ; Vandyke, K	1

Other Studies

2 other study(ies) available for flutamide and osteoprotegerin

Article	Year
Estrogen and testosterone use different cellular pathways to inhibit osteoclastogenesis and bone resorption. Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research, 2005, Volume: 20, Issue:12 Topics: Acid Phosphatase; Adult; Androgen Antagonists; Animals; Bone Resorption; Carrier Proteins; Cattle; Cell Differentiation; Cell Line, Tumor; Coculture Techniques; Dexamethasone; Dose-Response Relationship, Drug; Estradiol; Estrogen Antagonists; Estrogens; Flutamide; Fulvestrant; Glycoproteins; Humans; Isoenzymes; Lipopolysaccharide Receptors; Macrophage Colony-Stimulating Factor; Male; Membrane Glycoproteins; Monocytes; Osteoclasts; Osteoprotegerin; RANK Ligand; Receptor Activator of Nuclear Factor-kappa B; Receptors, Cytoplasmic and Nuclear; Receptors, Tumor Necrosis Factor; Tartrate-Resistant Acid Phosphatase; Testosterone; Tumor Necrosis Factor-alpha	2005
Androgen decreases osteoprotegerin expression in prostate cancer cells. Prostate cancer and prostatic diseases, 2007, Volume: 10, Issue:2 Topics: 5-alpha-Dihydroprogesterone; Androgens; Cell Line, Tumor; Flutamide; Gene Expression; Humans; Male; Osteoprotegerin; Prostatic Neoplasms; RNA, Messenger	2007

Article

Year

Estrogen and testosterone use different cellular pathways to inhibit osteoclastogenesis and bone resorption.

Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research, 2005, Volume: 20, Issue:12

Topics: Acid Phosphatase; Adult; Androgen Antagonists; Animals; Bone Resorption; Carrier Proteins; Cattle; Cell Differentiation; Cell Line, Tumor; Coculture Techniques; Dexamethasone; Dose-Response Relationship, Drug; Estradiol; Estrogen Antagonists; Estrogens; Flutamide; Fulvestrant; Glycoproteins; Humans; Isoenzymes; Lipopolysaccharide Receptors; Macrophage Colony-Stimulating Factor; Male; Membrane Glycoproteins; Monocytes; Osteoclasts; Osteoprotegerin; RANK Ligand; Receptor Activator of Nuclear Factor-kappa B; Receptors, Cytoplasmic and Nuclear; Receptors, Tumor Necrosis Factor; Tartrate-Resistant Acid Phosphatase; Testosterone; Tumor Necrosis Factor-alpha

2005

Androgen decreases osteoprotegerin expression in prostate cancer cells.

Prostate cancer and prostatic diseases, 2007, Volume: 10, Issue:2

Topics: 5-alpha-Dihydroprogesterone; Androgens; Cell Line, Tumor; Flutamide; Gene Expression; Humans; Male; Osteoprotegerin; Prostatic Neoplasms; RNA, Messenger

2007